The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 343:1566-1568 November 23, 2000 Number 21
NextNext

Roads Leading to Breast Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Cancer results from the accumulation of mutations in genes that regulate cellular proliferation. These mutations can occur early in the process of malignant transformation or later, during progression to an invasive carcinoma. The earliest mutations occur in the germ line, as in the case of cancer-prone families. In these instances, the inheritance of a mutated allele is commonly followed by the loss of the second allele from a somatic cell, leading to the inactivation of a tumor-suppressor gene and triggering malignant transformation. A classic example is hereditary retinoblastoma, in which there is inheritance of a mutant germ-line RB1 allele (a . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.